Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vivani Medical, Inc. - Common Stock
(NQ:
VANI
)
1.290
+0.050 (+4.03%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vivani Medical, Inc. - Common Stock
< Previous
1
2
3
Next >
Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant
September 04, 2024
From
Vivani Medical, Inc.
Via
Business Wire
EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity
September 04, 2024
Vivani Medical reports promising preclinical liver fat reduction results with its exenatide implant for obesity, showing potential as a differentiated treatment option. The LIBERATE-1 clinical trial is...
Via
Benzinga
Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
August 28, 2024
From
Vivani Medical, Inc.
Via
Business Wire
VANI Stock Earnings: Vivani Medical Beats EPS for Q2 2024
August 13, 2024
VANI stock results show that Vivani Medical beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results
August 13, 2024
From
Vivani Medical, Inc.
Via
Business Wire
Pineapple Financial And 1 Other Stock Under $1 Insiders Are Buying
August 05, 2024
Via
Benzinga
Vivani Medical And 2 Other Stocks Under $2 Insiders Are Buying
August 02, 2024
Via
Benzinga
Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115
July 11, 2024
From
Vivani Medical, Inc.
Via
Business Wire
EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year
July 11, 2024
Vivani Medical plans to start the first clinical study of the NPM-115 program in Australia in Q4 2024. The study will evaluate a 6-month GLP-1 implant for chronic weight management in obese or...
Via
Benzinga
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 13, 2024
Via
Benzinga
Why GLP-1 Developer Vivani Medical's Stock Is Climbing
June 13, 2024
Vivani Medical shares are trading higher Thursday after the company announced the FDA cleared the Investigational New Drug application and lifted the clinical hold on NPM-119.
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 13, 2024
Via
Benzinga
Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant
June 13, 2024
From
Vivani Medical, Inc.
Via
Business Wire
EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's NDA Gains FDA Clearance For Clinical Use
June 13, 2024
Vivani Medical cleared FDA for NPM-119 trial in type 2 diabetes. LIBERATE-1 will assess safety, tolerability, & pharmacokinetics. NPM-115 & NPM-139 also in development for weight management.
Via
Benzinga
Exposures
Product Safety
Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant
May 28, 2024
From
Vivani Medical, Inc.
Via
Business Wire
EXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Veterinary Use
May 28, 2024
Vivani Medical announced proof-of-concept data for a subdermal exenatide implant designed for feline obesity and diabetes, which was published in BMC Veterinary Research.
Via
Benzinga
VANI Stock Earnings: Vivani Medical Meets EPS for Q1 2024
May 13, 2024
VANI stock results show that Vivani Medical met analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
May 13, 2024
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical to Present at TIDES Conference 2024
May 09, 2024
From
Vivani Medical, Inc.
Via
Business Wire
VANI Stock Earnings: Vivani Medical Beats EPS for Q4 2023
March 26, 2024
VANI stock results show that Vivani Medical beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
March 26, 2024
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical Appoints Daniel Bradbury to its Board of Directors
March 06, 2024
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical Surges on its Ozempic-Like Weight-Loss Implant
March 06, 2024
The Ozempic craze continues to make headlines in the medical sector, and GLP-1 drug stocks such as Vivani Medical continue to surge higher
Via
MarketBeat
Exposures
Product Safety
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 04, 2024
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 04, 2024
Via
Benzinga
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 01, 2024
Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 01, 2024
Via
Benzinga
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
March 01, 2024
From
Vivani Medical, Inc.
Via
Business Wire
S&P 500 Edges Lower; ADT Posts Upbeat Earnings
February 28, 2024
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.27% to 38,867.91 while the NASDAQ fell 0.50% to 15,954.75. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.